
Description
Survodutide
GLP-1/glucagon dual agonist class peptide under clinical development. Review-required supply.
Technical identity, purity, packaging, and documentation are confirmed against the applicable product specification and batch COA before release.
Part of our peptide CDMO services range, supplied by a China peptide manufacturer with batch documentation.
| Attribute | Specification |
|---|---|
| Form | Lyophilized powder |
| Purity | Specified per order and verified by the applicable batch COA / analytical report |
| Molecular Formula | C192H289N47O61 |
| Molecular Weight | 4232 Da |
| Sequence | Modified glucagon/GLP-1 co-agonist peptide; includes a lipidated side chain |
| Solubility | Solubility is material-, concentration-, and buffer-dependent; use the applicable laboratory protocol and product specification |
| Storage | Store lyophilized material according to the product label and batch documentation; minimize repeated temperature cycling after preparation |
Supply is subject to buyer qualification and destination-market regulatory review. These products are not consumer offers and are not advertised to the public.



